It didn't take a high-powered academic to figure out why Scholar Rock's (NASDAQ: SRRK) share price swooned by more than 5% on Wednesday. That morning, the biotech published a quarterly earnings report and business update that fell short of expectations. That decline came on a day when the S&P 500 index rose by 0.7%.

Scholar Rock's second quarter saw the relatively early-stage company post no revenue and a net loss of over $110 million, or $0.98 per share. This was far steeper than the nearly $59 deficit in the same period of 2024.

Image source: Getty Images.

Continue reading

Source Fool.com